-+ 0.00%
-+ 0.00%
-+ 0.00%

VERTEX PHARMACEUTICALS INCORPORATED : SCOTIABANK RAISES TARGET PRICE TO $660 FROM $558

Reuters·11/03/2026 03:47:04